NewAmsterdam Pharma Company N.V. (NAMS)

NASDAQ

$21.44

$-0.07

(-0.33%)

Regular Market

NewAmsterdam Pharma Company N.V. (NAMS) Live Price Chart

Last updated: ⁦2026-10-21 18:57:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

NewAmsterdam Pharma Company N.V. (NAMS) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $21.44, with a market capitalization of $2.45B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $19.58 to $42.21. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$2.45B
Open	$21.58
Day's High	$42.21
Day's Low	$5.63
Previous Close	$21.50
Volume	889.31K
Average Volume	1.40M
P/E Ratio	--
52-Week High	$42.21
52-Week Low	$19.58
Dividend Yield	--
Earnings Date	--

NewAmsterdam Pharma Company N.V. (NAMS) Stock Price Today

NewAmsterdam Pharma Company N.V. (NAMS) is currently trading at $21.44 as of 2026-10-21 18:40:28, down 0.27% ($0.06) from the previous close of $21.50

During today's regular trading session, NAMS has traded between $5.63 and $42.21, with a trading volume of 889.31K shares. The current price is near the middle of today's range.

NewAmsterdam Pharma Company N.V. (NAMS) 7-Day Stock Price Change

Over the past seven days, NewAmsterdam Pharma Company N.V. (NAMS) moved from $21.25 to $21.44, representing a gain of 0.90% ($0.19).

The stock traded between $19.58 and $22.44 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.

The average daily volume was 1.23 million shares, down versus the previous seven-day period, indicating lower trading activity.

NAMS 52-Week Price Position

Position in Range: 8.2%

52W Low$19.58

52W High$42.21

NAMS is currently trading at $21.44, placing it 8.2% of the way from its 52-week low of $19.58 to its 52-week high of $42.21. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is NewAmsterdam Pharma Company N.V. (NAMS)?

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments. The Company has one reportable segment, which comprises the discovery, development, and commercialization of transformative therapies for cardio-metabolic diseases.

NewAmsterdam Pharma Company N.V. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	100
Exchange	NASDAQ
Company Website	https://www.newamsterdampharma.com

How to Buy NewAmsterdam Pharma Company N.V. (NAMS) Stock on MEXC

Eligible investors can buy real shares of NewAmsterdam Pharma Company N.V. (NAMS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for NAMS and Place Your Order

Open the RealStocks trading page and search for NAMS. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is NewAmsterdam Pharma Company N.V. (NAMS) stock price today?

NewAmsterdam Pharma Company N.V. (NAMS) is currently trading at $ 21.44, down 0.27% ($0.06) from the previous close of $ 21.50. Intraday prices update in real time during regular trading hours.

2.Is NAMS stock going up or down today?

As of 2026-10-21 18:40:28, NAMS is trading at $ 21.44, down 0.27% ($0.06) from its previous close of $ 21.50. The stock has traded between $ 5.63 and $ 42.21 during today’s regular session. Past price movements do not guarantee future results.

3.What is NAMS pre-market price?

As of 2026-10-21 18:40:28, NAMS is trading at $ 21.69 in pre-market trading, up 0.86% ($0.18) from the previous close of $ 21.50. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is NAMS after-hours price?

As of 2026-10-21 18:40:28, NAMS is trading at $ 21.50 in after-hours trading, unchanged from the regular-session close of $ 21.50. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is NAMS stock trading now?

NAMS trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does NAMS sit relative to its 52-week high and low?

Over the past 52 weeks, NAMS has traded between a low of $ 19.58 and a high of $ 42.21. At $ 21.44, the stock is positioned 8.2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is NewAmsterdam Pharma Company N.V. in?

NewAmsterdam Pharma Company N.V. (NAMS) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is NewAmsterdam Pharma Company N.V.'s market capitalization and where is it listed?

NewAmsterdam Pharma Company N.V. is listed on the NASDAQ exchange with a market capitalization of $ 2.45B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is NAMS valued in terms of P/E ratio and EPS?

NAMS trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -2.17. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does NewAmsterdam Pharma Company N.V. pay a dividend?

NewAmsterdam Pharma Company N.V. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.